Congress Unlikely To Complete Work On Reconciling PDUFA Legislation This Week, Congressional Aides Say

August 4, 2007 – 11:24 am | posted in Pharma Industry

Congress this week likely will not finalize a bill that would reauthorize the Prescription Drug User Fee Act and expand FDA oversight of prescription drug safety, despite a requirement that the agency distribute layoff notices in the event that lawmakers do not complete the legislation before the August recess, CongressDaily reports.

A House Energy and Commerce Committee aide on Tuesday confirmed that a conference committee to resolve differences between the House and Senate versions of the bill will not occur this week. Senate Health, Education, Labor and Pensions Committee ranking member Mike Enzi (R-Wyo.) also believes that Congress likely will not finalize the legislation this week, an aide said. In a letter to Senate leaders last week, Enzi raised concerns that the layoff notices would prompt FDA employees to seek other jobs.

House Chief Deputy Minority Whip Eric Cantor (R-Va.) has raised similar concerns and said FDA will distribute the layoff notices as early as this month. However, Rep. Debbie Wasserman Schultz (D-Fla.) said, “We think the gentleman’s characterization of the timing of that is a bit of a stretch.” Democrats have indicated they are not very concerned about the layoff notices because they believe FDA employees will ignore them with the legislation so close to finalization, CongressDaily reports (Edney, CongressDaily, 8/1).

Reprinted with kind permission from http://www.kaisernetwork.org. You can view the entire Kaiser Daily Health Policy Report, search the archives, or sign up for email delivery at http://www.kaisernetwork.org/dailyreports/healthpolicy. The Kaiser Daily Health Policy Report is published for kaisernetwork.org, a free service of The Henry J. Kaiser Family Foundation. © 2005 Advisory Board Company and Kaiser Family Foundation. All rights reserved.

Popularity: 1% [?]

Share This

Also Read

Dingell Considers Whether To Include Follow-on Biologics Measure In User Fee Reauthorization Bill

Congress During Lame-Duck Session Could Vote To Delay Scheduled Medicare Provider Payment Cuts

Exclusion Of Medicare From SCHIP Legislation Results In ‘Deep Concern And Disappointment’

Lawmakers Look To Improve Prescription Drug Safety Through User Fee Reauthorization Legislation

ADHA Applauds Congressional Action To Improve Access To Dental Care, USA

Many Physician Groups Have Not Endorsed Recently Approved Legislation That Would Delay Cuts To Medicare Doctor Fees, Establish Pay-for-Performance

Congressional Democrats Might Use Budget Reconciliation Process To Pass Medicare Bill

Congressional Democrats To Draft Bill To Overturn Supreme Court Decision On Medical Devices

AGD Applauds Congressional Approval Of SCHIP Reauthorization Bills - Urges Inclusion Of Dental Provisions In Final Bill, USA

Senate Approves Legislation To Reauthorize Bioterrorism Preparedness Law